Skip to main navigation
Skip to search
Skip to main content
Monash University Home
Help & FAQ
Home
Profiles
Research units
Equipment
Projects
Outputs
Prizes
Activities
Press/Media
Search by expertise, name or affiliation
TRANSFORM: A 52-week, Randomized, Placebo-controlled, Double-blind, Adaptive Phase 2b/3 Trial of Setanaxib with a 52-week Extension Phase in Patients with Primary Biliary Cholangitis (PBC) and Elevated Liver Stiffness.
Roberts, Stuart
(Primary Chief Investigator (PCI))
Gastroenterology
Project
:
Research
Overview
Project Details
Status
Active
Effective start/end date
26/02/22
→
1/01/26
View all
View less
Keywords
Hepatology
Gastroenterology
Clinical trial